Anna Radominska-Pandya Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

UAMS Contingent Worker

University of Arkansas for Medical Sciences

grad_student

Biochemistry & Molecular Biology, College of Medicine

Research Areas

Links

Lab Website UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Anna Radominska-Pandya's research investigates the molecular mechanisms underlying the development of multiple myeloma. Her work focuses on understanding the specific cellular pathways and genetic alterations that contribute to the progression of this blood cancer. This research aims to identify potential therapeutic targets for improved treatment strategies. Her affiliation is with the Department of Biochemistry & Molecular Biology at the University of Arkansas for Medical Sciences.

Grants & Funding

CARBOXYL-LINKED GLUCURONIDES OF BILE ACIDS NIH Principal Investigator
Glucuronidation of Fatty Acids by Human ER &Nuclear UGT NIH Principal Investigator
UDP-GLCUA TRANSFERASES--SPECIFIC UDP-GLCUA TRANSPORTER NIH Principal Investigator
HUMAN HEPATIC &INTESTINAL UDP GLUCURONOSYLTRANSFERASES NIH Principal Investigator
In vivo, noninvasive, ultrasensitive photoacoustic detection of early breast cancer metastasis in bone US Department of the Army Principal Investigator
Using Advanced Functional Nanomaterials to Fight Cancer. U.S. Army Medical Research & Materiel Command - Pass Through: University of Arkansas at Little Rock Principal Investigator
Synthetic Cannabinoid Toxicity: Role of Biotransformation NIH Co-Investigator
UDP-GLCUA TRANFERASES--SPECIFIC UDP-GLCUA TRANSPORTER NIH Principal Investigator